Disease | hartnup disease |
Comorbidity | C0409974|lupus erythematosus |
Sentences | 11 |
PubMedID- 21706294 | Associations of different assays for antibodies to c1q (anti-c1q) and to dsdna (anti-dsdna) and of complements c3 and c4 with disease activity in patients with systemic lupus erythematosus (sle) were studied. |
PubMedID- 22867055 | The enhanced expression of glk has been shown to correspond with disease severity in patients with systemic lupus erythematosus. |
PubMedID- 21558138 | Elevated circulating cd4+ icos+ foxp3+ t cells contribute to overproduction of il-10 and are correlated with disease severity in patients with systemic lupus erythematosus. |
PubMedID- 20879061 | Significantly higher percentage of circulating cd27(high) plasma cells in systemic lupus erythematosus patients with infection than with disease flare-up. |
PubMedID- 24013639 | Some of these snps affect multiple genes in trans that are known to be altered in individuals with disease: rs4917014, previously associated with systemic lupus erythematosus (sle), altered gene expression of c1qb and five type i interferon response genes, both hallmarks of sle. |
PubMedID- 19158114 | Increased erk and jnk activities correlate with disease activity in patients with systemic lupus erythematosus. |
PubMedID- 23251213 | Correlation of circulating glucocorticoid-induced tnfr-related protein ligand levels with disease activity in patients with systemic lupus erythematosus. |
PubMedID- 22712250 | [systemic lupus erythematosus: correlation of cutaneous manifestations with disease activity]. |
PubMedID- 22649532 | Cd8+ t lymphocytes play a significant role in autoimmune disorders, as demonstrated in several reports that identify that an increase in the number of activated cd8+ t lymphocytes expressing perforin and grb correlates with disease activity in patients with systemic lupus erythematosus [6] and multiple sclerosis [7]. |
PubMedID- 22324318 | It has been documented that hmgb1 is associated with disease activity in patients with systemic lupus erythematosus (sle). |
PubMedID- 20131231 | Antibodies to apolipoprotein a-i, high-density lipoprotein, and c-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. |
Page: 1